Malaria burden: $4billion needed

T he global health community faces a critical funding shortfall that threatens the timely distribution of malaria vaccines to millions of vulnerable children in Africa, according to a White Paper authored by 1Day Sooner and the Center for Global Development (CGD), informed by conversations with the World Health Organisation (WHO), among other partners. Despite unprecedented progress with malaria vaccines such as R21, a $4 billion funding gap endangers the goal of vaccinating all eligible children by 2030. Gavi, the Vaccine Alliance, has allocated $1.5 billion, covering only one-third of the estimated $4–5 billion needed. According to the white paper titled “Avoiding Another Lost Decade on Malaria Vaccines,” malaria remains a major public health crisis in Africa, accounting for 95% of global malaria deaths, most of which occur among children under five. Vaccines like R21 offer a transformative, cost-effective solution. Priced at just $3.90 per dose, and with a capacity to sa...